Kissei Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Kissei Pharmaceutical has a total shareholder equity of ¥197.6B and total debt of ¥1.4B, which brings its debt-to-equity ratio to 0.7%. Its total assets and total liabilities are ¥228.5B and ¥30.9B respectively. Kissei Pharmaceutical's EBIT is ¥2.5B making its interest coverage ratio -1.8. It has cash and short-term investments of ¥43.2B.
Key information
0.7%
Debt to equity ratio
JP¥1.39b
Debt
Interest coverage ratio | -1.8x |
Cash | JP¥43.21b |
Equity | JP¥197.59b |
Total liabilities | JP¥30.86b |
Total assets | JP¥228.45b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: KSPH.F's short term assets (¥102.2B) exceed its short term liabilities (¥17.2B).
Long Term Liabilities: KSPH.F's short term assets (¥102.2B) exceed its long term liabilities (¥13.6B).
Debt to Equity History and Analysis
Debt Level: KSPH.F has more cash than its total debt.
Reducing Debt: KSPH.F's debt to equity ratio has reduced from 2.1% to 0.7% over the past 5 years.
Debt Coverage: KSPH.F's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: KSPH.F earns more interest than it pays, so coverage of interest payments is not a concern.